In both IBD forms, levels of pro-inflammatory cytokines, such as IL-1β, TNF-α, and IL-6, were found to be increased [38-40], which suggest that these inflammatory mediators are engaged in determining the severity of the disease. This evidence concerns the gene TNF and inflammatory bowel disease.